| Mrs Lisa Sue Mccloud, FNP-BC | |
|
184 E 2nd Ave, Williamson, WV 25661-3602 | |
| (304) 235-2930 | |
| (304) 235-4202 |
| Full Name | Mrs Lisa Sue Mccloud |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 9 Years |
| Location | 184 E 2nd Ave, Williamson, West Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780132571 | NPI | - | NPPES |
| 2016009648 | Other | WV | ANCC CERTIFICATION # |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SF0001X | Clinical Nurse Specialist - Family Health | 61706 (West Virginia) | Primary |
| Entity Name | Medexpress Urgent Care Inc West Virginia |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912133315 PECOS PAC ID: 1254487101 Enrollment ID: O20090918000219 |
News Archive
Results of EORTC trial 62072 appearing in Cancer show that in patients with soft tissue sarcoma, whose disease had progressed during or after prior chemotherapy, pazopanib improved progression-free survival but did not change health-related quality of life. This observed improvement in progression-free survival without impairment of health-related quality of life was considered a meaningful result.
The Kenyatta National Hospital Ethics and Research Board recently approved the first human clinical trial in Kenya of an herbal product to treat HIV/AIDS, Kenya's Nation reports.
A team of researchers from the National University of Singapore has uncovered hidden vulnerabilities on the surface of the dengue virus. This novel discovery means that scientists can now develop strategies to target these weak spots for treatment of dengue, and possibly other closely related diseases like Zika, influenza and chikungunya.
Perhaps the most comprehensive, multi-institutional study yet of the sexually transmitted bacteria chlamydia is under way at the University of Maryland, Baltimore (UMB).
› Verified 4 days ago
| Entity Name | Mccloud Medical Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851968309 PECOS PAC ID: 9537539705 Enrollment ID: O20230104001010 |
News Archive
Results of EORTC trial 62072 appearing in Cancer show that in patients with soft tissue sarcoma, whose disease had progressed during or after prior chemotherapy, pazopanib improved progression-free survival but did not change health-related quality of life. This observed improvement in progression-free survival without impairment of health-related quality of life was considered a meaningful result.
The Kenyatta National Hospital Ethics and Research Board recently approved the first human clinical trial in Kenya of an herbal product to treat HIV/AIDS, Kenya's Nation reports.
A team of researchers from the National University of Singapore has uncovered hidden vulnerabilities on the surface of the dengue virus. This novel discovery means that scientists can now develop strategies to target these weak spots for treatment of dengue, and possibly other closely related diseases like Zika, influenza and chikungunya.
Perhaps the most comprehensive, multi-institutional study yet of the sexually transmitted bacteria chlamydia is under way at the University of Maryland, Baltimore (UMB).
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Lisa Sue Mccloud, FNP-BC 184 East 2nd Ave, Williamson, WV 25661 Ph: (304) 235-2930 | Mrs Lisa Sue Mccloud, FNP-BC 184 E 2nd Ave, Williamson, WV 25661-3602 Ph: (304) 235-2930 |
News Archive
Results of EORTC trial 62072 appearing in Cancer show that in patients with soft tissue sarcoma, whose disease had progressed during or after prior chemotherapy, pazopanib improved progression-free survival but did not change health-related quality of life. This observed improvement in progression-free survival without impairment of health-related quality of life was considered a meaningful result.
The Kenyatta National Hospital Ethics and Research Board recently approved the first human clinical trial in Kenya of an herbal product to treat HIV/AIDS, Kenya's Nation reports.
A team of researchers from the National University of Singapore has uncovered hidden vulnerabilities on the surface of the dengue virus. This novel discovery means that scientists can now develop strategies to target these weak spots for treatment of dengue, and possibly other closely related diseases like Zika, influenza and chikungunya.
Perhaps the most comprehensive, multi-institutional study yet of the sexually transmitted bacteria chlamydia is under way at the University of Maryland, Baltimore (UMB).
› Verified 4 days ago